CART ITEM (0)
report cover

Metastatic Melanoma Diagnostic Market, Global Outlook and Forecast 2023-2030

  • 15 November 2023
  • ICT & Media
  • 61 Pages
  • Report code : 24WT-7849830
sample cover   Download Free PDF sample

Metastatic Melanoma Diagnostic and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Metastatic Melanoma Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Melanoma Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Melanoma Diagnostic Overall Market Size
2.1 Global Metastatic Melanoma Diagnostic Market Size: 2022 VS 2030
2.2 Global Metastatic Melanoma Diagnostic Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metastatic Melanoma Diagnostic Players in Global Market
3.2 Top Global Metastatic Melanoma Diagnostic Companies Ranked by Revenue
3.3 Global Metastatic Melanoma Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Melanoma Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Metastatic Melanoma Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Metastatic Melanoma Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Metastatic Melanoma Diagnostic Market Size Markets, 2022 & 2030
4.1.2 BRAF Mutation
4.1.3 Circulating Tumor Cells (CTCs)
4.1.4 Immunohistochemistry
4.1.5 Others
4.2 By Type - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Metastatic Melanoma Diagnostic Revenue, 2018-2023
4.2.2 By Type - Global Metastatic Melanoma Diagnostic Revenue, 2024-2030
4.2.3 By Type - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Melanoma Diagnostic Market Size, 2022 & 2030
5.1.2 Pathology Laboratories
5.1.3 Hospitals
5.1.4 Cancer Research Centres
5.1.5 Others
5.2 By Application - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Metastatic Melanoma Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global Metastatic Melanoma Diagnostic Revenue, 2024-2030
5.2.3 By Application - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Metastatic Melanoma Diagnostic Market Size, 2022 & 2030
6.2 By Region - Global Metastatic Melanoma Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Metastatic Melanoma Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global Metastatic Melanoma Diagnostic Revenue, 2024-2030
6.2.3 By Region - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.3.2 US Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.3.3 Canada Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.3.4 Mexico Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.4.2 Germany Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.3 France Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.4 U.K. Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.5 Italy Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.6 Russia Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.7 Nordic Countries Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.4.8 Benelux Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.5.2 China Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.3 Japan Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.4 South Korea Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.5 Southeast Asia Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.5.6 India Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.6.2 Brazil Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.6.3 Argentina Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, 2018-2030
6.7.2 Turkey Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7.3 Israel Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7.4 Saudi Arabia Metastatic Melanoma Diagnostic Market Size, 2018-2030
6.7.5 UAE Metastatic Melanoma Diagnostic Market Size, 2018-2030
7 Metastatic Melanoma Diagnostic Companies Profiles
7.1 Myriad Genetics
7.1.1 Myriad Genetics Company Summary
7.1.2 Myriad Genetics Business Overview
7.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Major Product Offerings
7.1.4 Myriad Genetics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Myriad Genetics Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Major Product Offerings
7.2.4 Abbott Laboratories Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Company Summary
7.3.2 Foundation Medicine Business Overview
7.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Major Product Offerings
7.3.4 Foundation Medicine Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Foundation Medicine Key News & Latest Developments
7.4 Pathway Genomics Corporation
7.4.1 Pathway Genomics Corporation Company Summary
7.4.2 Pathway Genomics Corporation Business Overview
7.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Major Product Offerings
7.4.4 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Pathway Genomics Corporation Key News & Latest Developments
7.5 Cancer Genetics
7.5.1 Cancer Genetics Company Summary
7.5.2 Cancer Genetics Business Overview
7.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Major Product Offerings
7.5.4 Cancer Genetics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Cancer Genetics Key News & Latest Developments
7.6 Castle Biosciences
7.6.1 Castle Biosciences Company Summary
7.6.2 Castle Biosciences Business Overview
7.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Major Product Offerings
7.6.4 Castle Biosciences Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.6.5 Castle Biosciences Key News & Latest Developments
7.7 NeoGenomics
7.7.1 NeoGenomics Company Summary
7.7.2 NeoGenomics Business Overview
7.7.3 NeoGenomics Metastatic Melanoma Diagnostic Major Product Offerings
7.7.4 NeoGenomics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.7.5 NeoGenomics Key News & Latest Developments
7.8 Dermtech
7.8.1 Dermtech Company Summary
7.8.2 Dermtech Business Overview
7.8.3 Dermtech Metastatic Melanoma Diagnostic Major Product Offerings
7.8.4 Dermtech Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Dermtech Key News & Latest Developments
7.9 Sysmex Inostics
7.9.1 Sysmex Inostics Company Summary
7.9.2 Sysmex Inostics Business Overview
7.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Major Product Offerings
7.9.4 Sysmex Inostics Metastatic Melanoma Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Sysmex Inostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Metastatic Melanoma Diagnostic Market Opportunities & Trends in Global Market
Table 2. Metastatic Melanoma Diagnostic Market Drivers in Global Market
Table 3. Metastatic Melanoma Diagnostic Market Restraints in Global Market
Table 4. Key Players of Metastatic Melanoma Diagnostic in Global Market
Table 5. Top Metastatic Melanoma Diagnostic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Metastatic Melanoma Diagnostic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Metastatic Melanoma Diagnostic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Metastatic Melanoma Diagnostic Product Type
Table 9. List of Global Tier 1 Metastatic Melanoma Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Melanoma Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Metastatic Melanoma Diagnostic Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Metastatic Melanoma Diagnostic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Metastatic Melanoma Diagnostic Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2024-2030
Table 30. Myriad Genetics Company Summary
Table 31. Myriad Genetics Metastatic Melanoma Diagnostic Product Offerings
Table 32. Myriad Genetics Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 33. Myriad Genetics Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Metastatic Melanoma Diagnostic Product Offerings
Table 36. Abbott Laboratories Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Foundation Medicine Company Summary
Table 39. Foundation Medicine Metastatic Melanoma Diagnostic Product Offerings
Table 40. Foundation Medicine Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 41. Foundation Medicine Key News & Latest Developments
Table 42. Pathway Genomics Corporation Company Summary
Table 43. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product Offerings
Table 44. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 45. Pathway Genomics Corporation Key News & Latest Developments
Table 46. Cancer Genetics Company Summary
Table 47. Cancer Genetics Metastatic Melanoma Diagnostic Product Offerings
Table 48. Cancer Genetics Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 49. Cancer Genetics Key News & Latest Developments
Table 50. Castle Biosciences Company Summary
Table 51. Castle Biosciences Metastatic Melanoma Diagnostic Product Offerings
Table 52. Castle Biosciences Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 53. Castle Biosciences Key News & Latest Developments
Table 54. NeoGenomics Company Summary
Table 55. NeoGenomics Metastatic Melanoma Diagnostic Product Offerings
Table 56. NeoGenomics Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 57. NeoGenomics Key News & Latest Developments
Table 58. Dermtech Company Summary
Table 59. Dermtech Metastatic Melanoma Diagnostic Product Offerings
Table 60. Dermtech Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 61. Dermtech Key News & Latest Developments
Table 62. Sysmex Inostics Company Summary
Table 63. Sysmex Inostics Metastatic Melanoma Diagnostic Product Offerings
Table 64. Sysmex Inostics Metastatic Melanoma Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 65. Sysmex Inostics Key News & Latest Developments
List of Figures
Figure 1. Metastatic Melanoma Diagnostic Segment by Type in 2022
Figure 2. Metastatic Melanoma Diagnostic Segment by Application in 2022
Figure 3. Global Metastatic Melanoma Diagnostic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Metastatic Melanoma Diagnostic Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Metastatic Melanoma Diagnostic Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Melanoma Diagnostic Revenue in 2022
Figure 8. By Type - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 9. By Application - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 10. By Type - Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 12. By Application - Global Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 14. By Region - Global Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 15. By Country - North America Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 16. US Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 20. Germany Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 21. France Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 28. China Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 32. India Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 34. Brazil Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Metastatic Melanoma Diagnostic Revenue Market Share, 2018-2030
Figure 37. Turkey Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Metastatic Melanoma Diagnostic Revenue, (US$, Mn), 2018-2030
Figure 41. Myriad Genetics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Foundation Medicine Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cancer Genetics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Castle Biosciences Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NeoGenomics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dermtech Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sysmex Inostics Metastatic Melanoma Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

User License

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

Delivery Time

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

Payment Options

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

Report Delivery

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SIMILAR REPORTS


SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
  • Toshiba
  • yamaha
  • nest
  • hp
  • campbell
  • Deloitte
  • Panasonic
  • sit-group
  • Spirax-Sarco
  • Chevron
  • Zeiss
  • showa denko
  • rolandberger
  • valens
  • harris1
  • mckinsey
  • perkinscoie
  • Saviola
  • gelita
  • Allocatesoft
  • siva-group
  • Chevron
  • Zeiss
  • showa denko
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Metastatic Melanoma Diagnostic and Forecast Market

Leave This Empty: